Tapewire

NYSE · USD

CYH

COMMUNITY HEALTH SYSTEMS INC

Export transactions ↓
Tapewire entity
5628
SEC CIK
0001108109
Parsed reports
301

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 02, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
Tax withholdingCommon Stock 17,087 $10.18 $173,945.66
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 3

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,932

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC
HAMMONS KEVIN JPresident and CFO
GrantStock Options (Right to Buy) · Derivative 75,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-014987 · doc4.xml · derivative · entry 6

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2032-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC
HAMMONS KEVIN JPresident and CFO
GrantPerformance Based Restricted · Derivative 150,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014987 · doc4.xml · derivative · entry 5

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC
HAMMONS KEVIN JPresident and CFO
Exercise / conversionPerformance Based Restricted · Derivative 18,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014987 · doc4.xml · derivative · entry 4

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC
HAMMONS KEVIN JPresident and CFO
Tax withholdingCommon Stock 32,596 $10.18 $331,827.28
Disclosure

SEC source: 0001209191-22-014987 · doc4.xml · nonDerivative · entry 3

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,357

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC
HAMMONS KEVIN JPresident and CFO
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014987 · doc4.xml · nonDerivative · entry 2

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,953

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC
HAMMONS KEVIN JPresident and CFO
Exercise / conversionCommon Stock 36,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014987 · doc4.xml · nonDerivative · entry 1

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:04 UTC
STOCKTON KEVIN ARegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015016 · doc4.xml · derivative · entry 4

STOCKTON KEVIN A · CIK 0001862464 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-02-29

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:04 UTC
STOCKTON KEVIN ARegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015016 · doc4.xml · derivative · entry 3

STOCKTON KEVIN A · CIK 0001862464 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:04 UTC
STOCKTON KEVIN ARegional President
Tax withholdingCommon Stock 6,350 $10.18 $64,643.00
Disclosure

SEC source: 0001209191-22-015016 · doc4.xml · nonDerivative · entry 2

STOCKTON KEVIN A · CIK 0001862464 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,634

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:04 UTC
STOCKTON KEVIN ARegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015016 · doc4.xml · nonDerivative · entry 1

STOCKTON KEVIN A · CIK 0001862464 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,984

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:03 UTC
SMITH WAYNE TDirector · Executive Chairman
GrantStock Options (Right to Buy) · Derivative 90,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015013 · doc4.xml · derivative · entry 8

SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2032-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:03 UTC
SMITH WAYNE TDirector · Executive Chairman
GrantPerformance Based Restricted · Derivative 180,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015013 · doc4.xml · derivative · entry 7

SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:03 UTC
SMITH WAYNE TDirector · Executive Chairman
Exercise / conversionPerformance Based Restricted · Derivative 157,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015013 · doc4.xml · derivative · entry 6

SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 157,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:03 UTC
SMITH WAYNE TDirector · Executive Chairman
Tax withholdingCommon Stock 160,845 $10.18 $1,637,402.10
Disclosure

SEC source: 0001209191-22-015013 · doc4.xml · nonDerivative · entry 3

SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,059,196

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:03 UTC
SMITH WAYNE TDirector · Executive Chairman
GrantCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015013 · doc4.xml · nonDerivative · entry 2

SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,220,041

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:03 UTC
SMITH WAYNE TDirector · Executive Chairman
Exercise / conversionCommon Stock 315,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015013 · doc4.xml · nonDerivative · entry 1

SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,130,041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC
Simon Lynn TPresident and CMO
GrantStock Options (Right to Buy) · Derivative 40,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 6

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC
Simon Lynn TPresident and CMO
GrantPerformance Based Restricted · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 5

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC
Simon Lynn TPresident and CMO
Exercise / conversionPerformance Based Restricted · Derivative 52,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC
Simon Lynn TPresident and CMO
Tax withholdingCommon Stock 53,543 $10.18 $545,067.74
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,884

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC
Simon Lynn TPresident and CMO
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,427

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC
Simon Lynn TPresident and CMO
Exercise / conversionCommon Stock 105,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
GrantStock Options (Right to Buy) · Derivative 30,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 8

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-02-29

F5 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
GrantPerformance Based Restricted · Derivative 30,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 7

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F4 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F4 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
Exercise / conversionPerformance Based Restricted · Derivative 15,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 6

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
Tax withholdingCommon Stock 1,385 $10.18 $14,099.30
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 5

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 15,553

F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 4

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 16,938

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 2

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,019

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:00 UTC
Pitt Justin DEVP and General Counsel
Exercise / conversionCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 1

Pitt Justin D · CIK 0001900988 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,019

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:57 UTC
MEDLEY MARK BRegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015001 · doc4.xml · derivative · entry 4

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-02-29

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:57 UTC
MEDLEY MARK BRegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015001 · doc4.xml · derivative · entry 3

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:57 UTC
MEDLEY MARK BRegional President
Tax withholdingCommon Stock 3,936 $10.18 $40,068.48
Disclosure

SEC source: 0001209191-22-015001 · doc4.xml · nonDerivative · entry 2

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,709

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:57 UTC
MEDLEY MARK BRegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015001 · doc4.xml · nonDerivative · entry 1

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,645

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:56 UTC
MASON AUSTEN DRegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015000 · doc4.xml · derivative · entry 3

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-02-29

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:56 UTC
MASON AUSTEN DRegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015000 · doc4.xml · derivative · entry 2

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:56 UTC
MASON AUSTEN DRegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015000 · doc4.xml · nonDerivative · entry 1

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:55 UTC GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-014997 · doc4.xml · derivative · entry 4

Johnson Jason K · CIK 0001798438 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-02-29

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:55 UTC GrantPerformance Based Restricted · Derivative 25,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014997 · doc4.xml · derivative · entry 3

Johnson Jason K · CIK 0001798438 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:55 UTC Tax withholdingCommon Stock 5,497 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014997 · doc4.xml · nonDerivative · entry 2

Johnson Jason K · CIK 0001798438 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,945

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:55 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014997 · doc4.xml · nonDerivative · entry 1

Johnson Jason K · CIK 0001798438 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,442

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:54 UTC
Hingtgen TimDirector · CEO
GrantStock Options (Right to Buy) · Derivative 100,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-014993 · doc4.xml · derivative · entry 6

Hingtgen Tim · CIK 0001598637 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:54 UTC
Hingtgen TimDirector · CEO
GrantPerformance Based Restricted · Derivative 200,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014993 · doc4.xml · derivative · entry 5

Hingtgen Tim · CIK 0001598637 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:54 UTC
Hingtgen TimDirector · CEO
Exercise / conversionPerformance Based Restricted · Derivative 112,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014993 · doc4.xml · derivative · entry 4

Hingtgen Tim · CIK 0001598637 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 112,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:54 UTC
Hingtgen TimDirector · CEO
Tax withholdingCommon Stock 118,872 $10.18 $1,210,116.96
Disclosure

SEC source: 0001209191-22-014993 · doc4.xml · nonDerivative · entry 3

Hingtgen Tim · CIK 0001598637 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 736,178

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:54 UTC
Hingtgen TimDirector · CEO
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014993 · doc4.xml · nonDerivative · entry 2

Hingtgen Tim · CIK 0001598637 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 855,050

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:54 UTC
Hingtgen TimDirector · CEO
Exercise / conversionCommon Stock 225,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014993 · doc4.xml · nonDerivative · entry 1

Hingtgen Tim · CIK 0001598637 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 755,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:48 UTC GrantRestricted Stock Units · Derivative 17,682 $10.18 Strike: $0.00 $180,002.76
Disclosure

SEC source: 0001209191-22-014984 · doc4.xml · derivative · entry 3

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,682

Underlying: Common Stock · 17,682 shares

Expires not disclosed

F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company.

F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:48 UTC Exercise / conversionRestricted Stock Units · Derivative 11,356 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014984 · doc4.xml · derivative · entry 2

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,356 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company.

F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:48 UTC Exercise / conversionCommon Stock 11,356 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014984 · doc4.xml · nonDerivative · entry 1

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,168

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.